Guggenheim analysts initiated coverage of drug firm Pfizer at Buy with a $36 price target. Shares have lagged behind the market in recent years.
Pfizer Stock Has 29% Upside, Says a New Bull
Feb 24, 2024
Stay Ahead of the Curve: Subscribe Now to Receive Instant Breaking News Alerts Directly to Your Inbox!
- Latest
- Popular
